Front. Cell. Infect. Microbiol. Frontiers in Cellular and Infection Microbiology Front. Cell. Infect. Microbiol. 2235-2988 Frontiers Media S.A. 10.3389/fcimb.2025.1656235 Cellular and Infection Microbiology Correction Correction: Designing adjuvant formulations to promote immunogenicity and protective efficacy of Leptospira immunoglobulin-like protein a subunit vaccine Techawiwattanaboon Teerasit 1 2 Courant Thomas 3 Brunner Livia 3 Sathean-anan-kun Suwitra 1 2 Krangvichian Pratomporn 2 4 Iadsee Nutta 2 4 Nakornpakdee Yaowarin 5 Sangjun Noppadon 6 Komanee Pat 6 Collin Nicolas 3 Ruxrungtham Kiat 2 Patarakul Kanitha 1 2 * 1 Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand 2 Chula Vaccine Research Center (Chula VRC), Center of Excellence in Vaccine Research and Development, Chulalongkorn University, Bangkok, Thailand 3 Vaccine Formulation Institute, Plan-Les-Ouates, Switzerland 4 Medical Microbiology, Interdisciplinary Program, Graduate School, Chulalongkorn University, Bangkok, Thailand 5 Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand 6 Laboratory Animal Section, Analysis Division, Armed Force Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Kanitha Patarakul, Kanitha.Pa@chula.ac.th; kpatarakul@gmail.com

18 08 2025 2025 15 1656235 29 06 2025 29 07 2025 Copyright © 2025 Techawiwattanaboon, Courant, Brunner, Sathean-anan-kun, Krangvichian, Iadsee, Nakornpakdee, Sangjun, Komanee, Collin, Ruxrungtham and Patarakul. 2025 Techawiwattanaboon, Courant, Brunner, Sathean-anan-kun, Krangvichian, Iadsee, Nakornpakdee, Sangjun, Komanee, Collin, Ruxrungtham and Patarakul

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Correction on Designing adjuvant formulations to promote immunogenicity and protective efficacy of Leptospira immunoglobulin-like protein a subunit vaccine By Techawiwattanaboon T, Courant T, Brunner L, Sathean-anan-kun S, Krangvichian P, Iadsee N, Nakornpakdee Y, Sangjun N, Komanee P, Collin N, Ruxrungtham K and Patarakul K (2022) Front. Cell. Infect. Microbiol. 12:918629. doi: 10.3389/fcimb.2022.918629 Leptospira immunoglobulin-like protein A subunit vaccine adjuvant formulation neutral liposome squalene-in-water emulsion QS21 saponin QuilA saponin section-in-acceptance Molecular Bacterial Pathogenesis

The animal facility was misidentified in the Materials and Methods section.

A correction has been made to the section Materials and Methods, subsection Immunization and Challenge in Hamsters, paragraph 1:

The sentence originally read:

“Outbred golden Syrian hamsters were purchased from the North-East Animal Laboratory Center, Khon Kaen University, Thailand.”

It has been corrected to:

“Outbred golden Syrian hamsters were obtained from the Animal Unit, Faculty of Medicine, Khon Kaen University, Thailand, which served as the animal resource provider for this study.”

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.